wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Captain Jack who wrote (778)	5/25/1999 8:02:00 PM
From: Anthony Wong	of 942

SmithKline says FDA approved diabetes drug Avandia Tuesday May 25, 7:31 pm Eastern Time PHILADELPHIA, May 25 (Reuters) - SmithKline Beecham Plc(quote from Yahoo! UK & Ireland: SB.L) (NYSE:SBH - news) has been granted U.S. regulatory approval to sell its Avandia drug for adult-onset type II diabetes, as a stand-alone therapy and in combination with another drug, metformin, the company said on Tuesday. Avandia, which will be co-marketed by British-based SmithKline Beecham and U.S.-based Bristol-Myers Squibb Co. (NYSE:BMY - news), won a recommended rating from a Food and Drug Administration advisory panel last month. It is among the first three members of the new glitazone class of diabetes drugs, which include Rezulin, sold by New Jersey-based Warner-Lambert Co. (NYSE:WLA - news), and Actos, under development by Japan's Takeda Chemical Industries Ltd. . biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next